OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.310
-0.010 (-0.76%)
Aug 3, 2026, 4:00 PM EDT - Market closed
OPKO Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 978 | 956 | 987 | 1,168 | 966 | 3,278 | |
Market Cap Growth | 3.50% | -3.12% | -15.46% | 20.90% | -70.53% | 23.84% |
Enterprise Value | 1,075 | 976.79 | 1,051 | 1,381 | 1,099 | 3,390 |
Last Close Price | 1.31 | 1.26 | 1.47 | 1.51 | 1.25 | 4.81 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 88.08 | 88.08 | 88.08 | 88.08 | 103.61 |
PEG Ratio | - | 55.80 | 55.80 | 55.80 | 55.80 | 55.80 |
PS Ratio | 1.66 | 1.58 | 1.38 | 1.35 | 0.96 | 1.85 |
PB Ratio | 0.83 | 0.75 | 0.72 | 0.84 | 0.62 | 1.95 |
P/TBV Ratio | 33.31 | 13.07 | 41.50 | - | - | 12.34 |
P/FCF Ratio | - | - | - | - | - | 530.28 |
P/OCF Ratio | - | - | - | - | - | 85.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.83 | 1.61 | 1.47 | 1.60 | 1.09 | 1.91 |
EV/EBITDA Ratio | - | - | - | - | - | 34.78 |
EV/EBIT Ratio | - | - | - | - | - | 180.82 |
EV/FCF Ratio | - | - | - | - | - | 548.50 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.32 | 0.30 | 0.35 | 0.21 | 0.17 | 0.14 |
Debt / EBITDA Ratio | - | - | - | - | - | 2.54 |
Debt / FCF Ratio | - | - | - | - | - | 40.02 |
Net Debt / Equity Ratio | 0.08 | 0.02 | 0.05 | 0.15 | 0.09 | 0.07 |
Net Debt / EBITDA Ratio | -1.90 | -0.17 | -1.18 | -4.12 | -1.13 | 1.16 |
Net Debt / FCF Ratio | - | - | -0.31 | -4.79 | -1.11 | 18.22 |
Asset Turnover | 0.23 | 0.29 | 0.34 | 0.41 | 0.44 | 0.73 |
Inventory Turnover | 5.45 | 6.54 | 8.08 | 7.80 | 8.92 | 10.90 |
Quick Ratio | 2.56 | 3.13 | 2.85 | 1.10 | 1.31 | 1.19 |
Current Ratio | 3.35 | 3.97 | 3.43 | 1.55 | 1.85 | 2.49 |
Return on Equity (ROE) | -5.95% | -17.14% | -3.86% | -12.80% | -20.23% | -1.80% |
Return on Assets (ROA) | -2.33% | -5.31% | -4.87% | -7.67% | -8.78% | 1.62% |
Return on Invested Capital (ROIC) | -3.47% | -8.08% | -6.76% | -9.72% | -11.48% | 2.14% |
Return on Capital Employed (ROCE) | -2.78% | -6.19% | -7.96% | -8.34% | -11.25% | 0.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
FCF Yield | - | 0.00% | - | - | - | 0.19% |
Buyback Yield / Dilution | -12.40% | -8.23% | 7.68% | -4.55% | -10.95% | -1.16% |
Total Shareholder Return | -12.40% | -8.23% | 7.68% | -4.55% | -10.95% | -1.16% |